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Exploring the Risk of
Unintended Consequences
of Quality Improvement Efforts
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“. . . experience from industrial disasters suggests
that it’s harder than it looks to develop
safety measures that don’t bite back.”
—T. Hartford (1)
An increasing focus on the quality of care has led to a
proliferation of process and outcome measures to allow for
the measurement of quality. For the year 2012, the Center
for Medicare and Medicaid Services has proposed a total of
367 quality measures (2). At face value, all of these quality
measures appear reasonable and assess endpoints of definite
clinical importance. However, many of these measures can
be seen as approaching quality from a fairly univariate and
static view. The measures largely assume that deficiencies in
quality can be addressed in a fairly straightforward and
direct manner without untoward effects. However, the
clinical reality is that many of these measures have complex
and dynamic interrelationships with other measures of
quality such as patient access to care, appropriateness of
care, and surveillance rates of diagnostic testing. As such,
efforts to improve these measures may lead to unintended
consequences. Our understanding of the complete spectrum
of unintended consequences remains in its early stages, but
some common themes have become increasingly evident.
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Quality measures that focus on mortality can lead to the
phenomenon of risk avoidance where patients at high risk of
adverse outcomes are denied beneficial clinical care (3).
With public reporting of percutaneous coronary intervention–
related mortality in Massachusetts, the proportion of pa-
tients treated with cardiogenic shock fell from 2.28% to
1.29% over the 3-year period from 2003 to 2005 (3).
Paradoxically, these highest-risk patients with cardiogenic
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this paper to disclose.shock are those that derive the most absolute benefit from
treatment (4). Thus, an improvement in the numerical
mortality rate within a quality measure may not actually
reflect quality of care improvements but may rather be due
to denial of needed care to the highest risk patients.
Quality measures that focus on an outcome that is
dependent on the level of surveillance may adversely impact
providers who are more attentive to diagnosing disease as
opposed to those who are less diligent (5). The diagnosis of
deep venous thrombosis is directly related to the utilization
rate of vascular ultrasound. Thus, differences in the occur-
rence of deep venous thrombosis may reflect utilization
patterns of vascular ultrasound rather than quality differ-
ences. In centers with high utilization rates of vascular
ultrasound, clinicians may improve their rates of deep
venous thrombosis diagnoses by reducing their utilization
rates. However, this endeavor can lead to underdiagnosis
and undertreatment of patients with resultant harm.
Quality measures can increase the focus on clinical
documentation rather than true quality. In patients under-
going primary percutaneous intervention for ST-segment
elevation myocardial infarction (STEMI), documentation
of a nonsystem reason for delay can allow for exclusion from
public reporting. In fact, the proportion of patients with a
door-to-balloon time 90 min and a documented reason
for delay allowing exclusion from public reporting has
increased from 3.7% to 8.1% between the years 2005 and
2010 (6). Some of this increase may reflect more accurate
documentation practices, but at its most extreme, clinicians
may “game” the system to avoid potential negative profes-
sional, reputational, or financial consequences associated
with measure reporting (7).
Quality measures may also be proposed and implemented
before a complete understanding of their potential solutions.
Hospital readmissions after heart failure and myocardial
infarction are certainly common and costly; however, our
understanding of how clinicians can reduce readmission
rates without limiting the provision of appropriate care
remains largely unknown (8). Therefore, costly and burden-
some efforts to improve the measure may be implemented
without any definite evidence of their true impact.
Given the increasing awareness of the risk of unintended
consequences of quality improvement, the study by Patel et
al. (9) in this issue of the Journal is both timely and of great
clinical importance. For more than 2 decades, the provision
of pre-hospital electrocardiogram (ECG) for early identifi-
cation of STEMI has been recommended to reduce the time
to treatment (10). Most reports have consistently shown a
15- to 20-min reduction in door-to-balloon time with
pre-hospital ECG (11). However, before this study, it was
unclear if widespread integration of pre-hospital ECG
would lead to increased ambulance scene time, negating the
benefits of reduced door-to-balloon times and ultimately
causing an increase in overall time to treatment (12).
Furthermore, only a very small minority (5%) of patients
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ECG (13). Therefore, a very large population of patients
has to be exposed to this pre-hospital intervention, although
only a very small number will actually benefit. For these
reasons, a pre-hospital ECG protocol could cause a delay in
ambulance scene time when implemented across the very
large population of patients presenting with chest pain.
Focusing their attention on the experience within the city
of San Diego, these investigators analyzed a very large (N
21,742) real-life population before and the after the imple-
mentation of a pre-hospital ECG program to allow for early
diagnosis of STEMI. Of 9,631 patients with chest pain of
suspected cardiac origin screened with the pre-hospital
ECG protocol, only 303 patients had STEMI identified
vividly, thus illustrating the very large population of patients
who had to be treated with this intervention. The overall
impact of the pre-hospital ECG protocol on scene time
(min:s) (19:10 vs. 19:28, p  0.002) and transport time
(13:16 vs. 13:28, p  0.007) was extremely modest and
almost certainly not clinically significant. Furthermore,
there appeared to be a small 3-min improvement in
scene-to-hospital time for STEMI patients, although this
finding was confounded by the lack of a STEMI control
group. This work conclusively alleviates the concerns of
scene delays associated with pre-hospital ECG implemen-
tation in a very large real-life population.
The work by this group should encourage other investi-
gators to systematically analyze quality improvement proj-
ects for unintended consequences and risks. As a whole, we
have assumed a much higher level of certainty of benefit of
our quality measures and quality improvement efforts. In
fact, the reality is that many of our quality improvement
efforts, no matter how well intentioned and designed, will
have no or a deleterious impact on quality. Therefore, the
implementation of a quality improvement project should be
accompanied by a well-designed protocol of clinical
follow-up and statistical analysis to assure that a true improve-
ment has occurred. Furthermore, as shown by the work of
Patel et al., the results of these quality improvement efforts
should be ultimately published for the benefit of all.
The intense focus on improving clinical quality will only
increase in the future. Of the many quality measures being
considered, some will lead to true clinical benefit to patients,
some will have no impact, and some will lead to patient
harm. The challenge and opportunity for clinicians today is
to identify which of these many quality measures will lead toa true and durable improvement in the quality of patient
care.
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